Precigen (PGEN) Stock Price, Quote, News & History | Benzinga

Precigen Inc (PGEN) Stock Price, Quote, News & History

PGENNASDAQ

Trade with Public

Trade with Public

$6.10

-0.39-6.01%

At close: Aug 14, 5:00 PM EST

$6.11

0.010.16%

After Hours: Aug 14, 7:48 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$6.32

Close

$6.10

Volume / Avg.

7.96M / 5.20M

Day Range

$6.08 - $6.40

52 Wk Range

1.80 - 7.32

Market Cap

$2.19B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

21.54%

Days to Cover

11.12

Recent Precigen, Inc. News

Toast To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP Morgan downgraded Ball, Needham raised Hinge Health.

Avi Kapoor

Why Arista Networks Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

Arista Networks Inc (ANET) reported strong Q2 results, with revenue of $3.04B, up 37.7% YoY. Shares rose 13% in pre-market trading.

Avi Kapoor

Partner Content

Precigen Gains Advantage As PAPZIMEOS Granted Orphan Drug Exclusivity By FDA; Long-Term Data From Clinical Study Encouraging

Why Cisco Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

Cisco Inc (NASDAQ: CSCO) beat expectations and raised guidance with $15.84B revenue and $1.06 EPS. Shares jumped 17.3% in pre-market trading.

Avi Kapoor

Partner Content

Precigen Reports 'Robust Uptake' Of New Drug For Rare Respiratory Disease; First Quarter Revenue Expected To Top $18 Million

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-114.17M

Investing Cash Flow (TTM)

24.14M

Financing Cash Flow (TTM)

92.57M

Free Cash Flow (TTM)

-115.22M

Capital Expenditure (TTM)

-1.06M

Net Change in Cash (TTM)

2.54M

Analyst Trends and Forecast

1

Mar

2

May

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Strong Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.24B

PE Ratio (TTM)

-

PE Ratio (FWD)

46.30

PEG Ratio (TTM)

-

PS Ratio (TTM)

28.05

PB Ratio (TTM)

53.16

Earnings Yield % (TTM)

-16.54%

Earnings Yield % (FWD)

2.16%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.12

Company Debt

Total Debt

$93.88M

LT Debt

$93.88M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$16.33M

Debt to Equity

2.26

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$6.32

Close

$6.10

Volume / Avg.

7.96M / 5.20M

Day Range

$6.08 - $6.40

52 Wk Range

1.80 - 7.32

Market Cap

$2.19B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

21.54%

Days to Cover

11.12

About

Sector

Health Care

Industry

Biotechnology

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Precigen (PGEN) stock?

A

You can purchase shares of Precigen (NASDAQ:PGEN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Precigen (PGEN) competitors?

A

Other companies in Precigen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Precigen (PGEN) stock?

A

Precigen has a consensus price target of $9.83.

Q

What is the current price for Precigen (PGEN)?

A

The stock price for Precigen (NASDAQ: PGEN) is $6.11 last updated August 14, 2026 at 7:48 PM EDT.

Q

Does Precigen (PGEN) pay a dividend?

A

There are no upcoming dividends for Precigen.

Q

When is Precigen (NASDAQ:PGEN) reporting earnings?

A

Precigen does not have any upcoming earnings scheduled.

Q

Is Precigen (PGEN) going to split?

A

There is no upcoming split for Precigen.

Q

What sector and industry does Precigen (PGEN) operate in?

A

Precigen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.